2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.09+$0.09 (+1.00%)
Price as of Jun 23, 2026 4:46 PM EDT- $1.5BMarket Cap
- 42.63%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.09+$0.09 (+1.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 685.0M +0.42% | 682.2M -30.65% | 983.7M -50.36% | 2.0B +72.89% | |
Cost of Revenue | 73.0M -63.97% | 202.7M -41.02% | 343.8M -61.92% | 902.6M N/A | |
Gross Profit | 612.0M +27.65% | 479.4M -25.08% | 639.9M -40.70% | 1.1B -5.85% | |
Sales and Marketing Expense | 157.5M -53.30% | 337.2M +268.51% | 91.5M +8.93% | 84.0M N/A | |
Research and Development Expense | -342.3M -12.49% | -391.2M -46.96% | -737.5M -40.30% | -1.2B -51.26% | |
Depreciation and Amortization Expense | 27.6M -43.06% | 48.5M +17.64% | 41.2M +41.89% | 29.1M +129.48% | |
Total Operating Expenses | 670.7M -27.97% | 931.1M -39.94% | 1.6B -40.98% | 2.6B -7.28% | |
Operating Profit | 452.8M +281.90% | -248.9M -56.06% | -566.5M -12.13% | -644.7M -61.77% | |
Interest Income | 29.5M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -11.5M +10.52% | -10.4M -27.65% | -14.4M -27.48% | -19.9M -5.90% | |
Interest Income and Expense and Net | 18.0M +272.32% | -10.4M -27.65% | -14.4M -27.48% | -19.9M -5.90% | |
Total Nonoperating Income and Expense | 40.6M +0.47% | 40.4M +6.72% | 37.9M +245.48% | 11.0M +233.82% | |
Income before Taxes | 442.2M +350.36% | -176.6M -67.48% | -543.0M -16.92% | -653.6M -61.88% | |
Income Taxes | 1.9M -82.86% | 10.9M +435.89% | 2.0M -52.68% | 4.3M -85.31% | |
Extraordinary Items | 4.9M +18.10% | 4.1M -59.01% | 10.1M N/A | N/A N/A | |
Net Income | 440.3M +334.83% | -187.5M -65.60% | -545.1M -17.16% | -657.9M -62.27% | |
Net Income from Continuing Operations Applicable to Common | 442.2M +350.36% | -176.6M -67.48% | -543.0M -16.92% | -653.6M -61.88% | |
Basic EPS and Net Income | 2.72 +321.14% | -1.23 -77.26% | -5.41 -35.75% | -8.42 -64.08% | |
Diluted EPS and Net Income | 2.58 +309.76% | -1.23 -77.26% | -5.41 -35.75% | -8.42 -64.08% | |
Basic Weighted Average Shares | 162.0M +6.44% | 152.2M +51.03% | 100.8M +28.89% | 78.2M +5.08% | |
Diluted Weighted Average Shares | 173.1M +13.74% | 152.2M +51.03% | 100.8M +28.89% | 78.2M +5.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 240.6M -54.62% | 530.2M -6.73% | 568.5M -57.48% | 1.3B -11.76% | |
Short-Term Investments | 494.4M +25.85% | 392.9M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 735.1M -20.37% | 923.1M +62.38% | 568.5M -57.48% | 1.3B -11.76% | |
Total Current Assets | 978.3M -13.35% | 1.1B -1.31% | 1.1B -32.85% | 1.7B -20.96% | |
Accumulated Depreciation | 40.6M -17.36% | 49.2M -34.43% | 75.0M +58.52% | 47.3M +58.16% | |
Property and Plant and Equipment and Net | 44.8M -67.63% | 138.4M -54.73% | 305.8M +3.92% | 294.2M +28.66% | |
Total Long-Term Assets | 17.1M -28.85% | 24.0M -31.74% | 35.2M +23.50% | 28.5M -49.78% | |
Total Assets | 1.2B -24.60% | 1.6B -13.19% | 1.8B -20.42% | 2.3B -12.34% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 324.9M N/A | |
Total Current Liabilities | 459.9M -60.16% | 1.2B -29.40% | 1.6B -33.53% | 2.5B +2.91% | |
Total Long-Term Debt | 244.2M +43.92% | 169.7M +0.99% | 168.0M +0.93% | 166.5M -48.54% | |
Total Long-Term Liabilities | 239.1M -33.52% | 359.6M +985.46% | 33.1M -40.52% | 55.7M +32.23% | |
Total Liabilities | 1.3B -40.29% | 2.2B -13.13% | 2.5B -13.08% | 2.9B -1.22% | |
Retained Earnings | -4.6B -8.79% | -5.0B +3.89% | -4.8B +12.75% | -4.3B +18.19% | |
Total Stockholders Equity | -127.8M -79.52% | -623.8M -12.98% | -716.9M +13.07% | -634.1M +80.30% | |
Total Shares Outstanding | 162.6M +1.34% | 160.4M +14.99% | 139.5M +62.14% | 86.0M +13.45% | |
Cash Flow | |||||
Cash from Operating Activities | -244.6M +180.34% | -87.3M -87.78% | -714.0M +71.65% | -415.9M -228.79% | |
Capital Expenditures | 5.6M -57.42% | 13.1M -75.72% | 53.8M -39.62% | 89.1M +54.92% | |
Cash from Investing Activities | -78.3M -61.64% | -204.0M +246.97% | -58.8M -36.76% | -93.0M -192.84% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 27.7M -89.36% | 260.6M +5,734.82% | 4.5M -98.63% | 325.0M -29.61% | |
Financials Ratio | |||||
Gross Margin | 89.34% +27.12% | 70.28% +8.03% | 65.05% +19.46% | 54.46% N/A | |
Operating Margin | 66.10% +281.13% | -36.49% -36.64% | -57.59% +77.03% | -32.53% -77.89% | |
Return on Assets | 32.17% +388.11% | -11.17% -58.45% | -26.88% -1.24% | -27.21% -67.55% | |
Return on Equity | -117.16% -518.91% | 27.97% -65.34% | 80.69% -39.55% | 133.49% +110.55% | |
Revenue Growth | 0.42% +101.38% | -30.65% -39.14% | -50.36% -169.09% | 72.89% -48.31% | |
Current Ratio | 2.13 +117.50% | 0.98 +39.78% | 0.70 +1.03% | 0.69 -23.19% | |
Cash Ratio | 0.52 +13.91% | 0.46 +32.10% | 0.35 -36.03% | 0.54 -14.26% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | -0.23 -69.75% | -0.77 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.09 -57.01% | 0.22 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow